POGO's Staff Scientist Says New Doctor Rules Promote Transparency

Tweet

February 12, 2013

New disclosure rules for doctors on advisory panels for the Food and Drug Administration are meant to increase transparency without discouraging doctors from serving on the panels, according to Ned Feder, the Project On Government Oversight's staff scientist. Feder was on Public News Service to discuss new rules for drug companies and medical device makers as part of the Affordable Care Act. \

According to Feder, increased transparency should help identify conflicts of interest among doctors who have a financial stake in drugs or devices they evaluate. 

It's hard to imagine that a person receiving this kind of payment will maintain complete objectivity over the value of the drug, its safety and its effectiveness.

You can listen to the segment by clicking here.

Topics: Public Health and Science

Related Content: Conflicts of Interest, Federal Advisory Committees, Food and Drug Administration (FDA), Integrity in Science, Medical Devices, Public Health, Science Policy

Authors: Andre Francisco

Project On Government Oversight (POGO)

1100 G Street, NW, Suite 500    Washington, DC 20005
Phone: (202) 347-1122     Fax: (202) 347-1116     Email: info@pogo.org

POGO is a 501(c)(3) organization. All donations are tax-deductible.

Founded in 1981, the Project On Government Oversight is a nonpartisan independent watchdog that champions good government reforms. POGO’s investigations into corruption, misconduct, and conflicts of interest achieve a more effective, accountable, open, and ethical federal government.